<PAGE>

================================================================================


                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549


                                    FORM 10-Q

               QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934

                  FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2004

                          COMMISSION FILE NO. 000-25064


                           HEALTH FITNESS CORPORATION
             (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)


                MINNESOTA                                   NO. 41-1580506
     (STATE OR OTHER JURISDICTION OF                        (IRS EMPLOYER
      INCORPORATION OR ORGANIZATION)                     IDENTIFICATION NO.)

           3600 AMERICAN BOULEVARD WEST, BLOOMINGTON, MINNESOTA 55431
                    (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)

                  REGISTRANT'S TELEPHONE NUMBER (952) 831-6830


      Indicate by check mark whether the registrant (1) filed all reports
required to be filed by Section 13 or 15(d) of the Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. YES [X] NO [ ]

      Indicate by check mark whether the registrant is an accelerated filer (as
defined in Exchange Act Rule 12b-2). YES [ ] NO [X]

      The number of shares outstanding of the registrant's common stock as of
August 6, 2004 was: Common Stock, $0.01 par value, 12,560,976 shares

================================================================================
<PAGE>
                           HEALTH FITNESS CORPORATION
                        CONSOLIDATED FINANCIAL STATEMENTS
                                TABLE OF CONTENTS


<TABLE>
<CAPTION>
                                                                                       PAGE
<S>                                                                                    <C>
    PART I.       FINANCIAL INFORMATION

         Item 1.  Consolidated Financial Statements (unaudited)

                        Consolidated Balance Sheets as of June 30, 2004 and              3
                        December 31, 2003

                        Consolidated Statements of Earnings for the three and six        4
                        months ended June 30, 2004 and 2003

                        Consolidated Statements of Cash Flows for the six                5
                        months ended June 30, 2004 and 2003

                        Notes to Consolidated Financial Statements                       6

         Item 2.  Management's Discussion and Analysis of Financial Condition           12
                  and Results of Operations


         Item 3.  Quantitative and Qualitative Disclosures About Market Risk            16

         Item 4.  Controls and Procedures                                               16


    PART II.          OTHER INFORMATION                                                 17

         Item 1.  Legal Proceedings                                                     17

         Item 2.  Changes in Securities, Use of Proceeds and Issuer Purchase of         17
                  Securities

         Item 3.  Defaults Upon Senior Securities                                       17

         Item 4.  Submission of Matters to a Vote of Security Holders                   17

         Item 5   Not Applicable                                                        18

         Item 6.  Exhibits and reports on Form 8-K                                      18

         Signatures                                                                     19

         Exhibit Index                                                                  20
</TABLE>



                                       2
<PAGE>
                           HEALTH FITNESS CORPORATION
                           CONSOLIDATED BALANCE SHEETS
                                   (UNAUDITED)

<TABLE>
<CAPTION>
                                                                             June 30,      December 31,
                                                                               2004            2003
                                                                           ------------    ------------
<S>                                                                        <C>             <C>
ASSETS

CURRENT ASSETS
    Cash                                                                   $         --    $    281,294
    Trade and other accounts receivable, less allowances of $145,800
       and $131,000                                                           7,374,545       5,218,224
    Prepaid expenses and other                                                  348,538         187,347
    Deferred tax assets                                                       1,100,300         850,300
                                                                           ------------    ------------
           Total current assets                                               8,823,383       6,537,165

PROPERTY AND EQUIPMENT, net                                                     178,187         177,217

OTHER ASSETS
    Goodwill                                                                  8,919,140       8,725,574
    Customer contracts, less accumulated amortization of $471,500
       and $67,400                                                            1,258,472       1,662,639
    Trademark, less accumulated amortization of $40,800 and $5,800              309,166         344,166
    Other intangible assets, less accumulated amortization of $19,300           123,520         138,582
       and $4,200
    Cash held in escrow                                                         473,738         471,999
    Deferred tax assets                                                         991,308       1,686,301
    Other                                                                        44,610          64,458
                                                                           ------------    ------------
                                                                           $ 21,121,524    $ 19,808,101
                                                                           ============    ============

LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES
    Trade accounts payable                                                 $    347,042    $    569,730
    Accrued salaries, wages, and payroll taxes                                1,854,136       1,607,157
    Other accrued liabilities                                                   438,857         450,255
    Accrued self funded insurance                                               646,784         228,084
    Deferred revenue                                                          1,433,533       1,427,057
                                                                           ------------    ------------
           Total current liabilities                                          4,720,352       4,282,283

LONG-TERM OBLIGATIONS                                                         4,269,000       4,350,012

COMMITMENTS AND CONTINGENCIES                                                        --              --

CUMULATIVE CONVERTIBLE PREFERRED STOCK, 10,000,000 shares
    authorized, 1,033,751 and 1,003,833 issued and outstanding                1,487,032       1,443,833

STOCKHOLDERS' EQUITY
    Common stock, $0.01 par value; 50,000,000 shares authorized;
       12,508,345 and 12,357,334 shares issued and outstanding                  125,083         123,573
    Additional paid-in capital                                               17,779,151      17,671,536
    Accumulated comprehensive income                                              2,288           5,707
    Accumulated deficit                                                      (7,261,382)     (8,068,843)
                                                                           ------------    ------------
                                                                             10,645,140       9,731,973
                                                                           ------------    ------------
                                                                           $ 21,121,524    $ 19,808,101
                                                                           ============    ============
</TABLE>


See notes to consolidated financial statements.



                                       3
<PAGE>
                           HEALTH FITNESS CORPORATION
                       CONSOLIDATED STATEMENTS OF EARNINGS
                                   (UNAUDITED)

<TABLE>
<CAPTION>
                                                       Three Months Ended             Six Months Ended
                                                             June 30,                      June 30,
                                                 ----------------------------    ----------------------------
                                                      2004            2003           2004            2003
                                                 ------------    ------------    ------------    ------------
<S>                                              <C>             <C>             <C>             <C>
REVENUE                                          $ 13,129,715    $  7,732,626    $ 25,796,089    $ 15,250,831

COSTS OF REVENUE                                    9,687,357       6,151,484      19,266,794      12,015,290
                                                 ------------    ------------    ------------    ------------
GROSS PROFIT                                        3,442,358       1,581,142       6,529,295       3,235,541

OPERATING EXPENSES
    Salaries                                        1,429,569         789,216       2,772,278       1,572,758
    Other selling, general and administrative         823,504         421,605       1,653,610         830,919
    Amortization of acquired intangible assets        219,583              --         439,167              --
                                                 ------------    ------------    ------------    ------------
           Total operating expenses                 2,472,656       1,210,821       4,865,055       2,403,677
                                                 ------------    ------------    ------------    ------------

OPERATING INCOME                                      969,702         370,321       1,664,240         831,864

OTHER INCOME (EXPENSE)
    Interest expense                                 (128,344)        (13,451)       (262,596)        (23,956)
    Other, net                                            469            (831)          1,390          (1,859)
                                                 ------------    ------------    ------------    ------------
EARNINGS BEFORE INCOME TAXES                          841,827         356,039       1,403,034         806,049

INCOME TAX EXPENSE                                    342,873         138,706         552,373         320,736
                                                 ------------    ------------    ------------    ------------

NET EARNINGS                                          498,954         217,333         850,661         485,313

    Dividend to preferred shareholders                 28,200              --          43,200              --
                                                 ------------    ------------    ------------    ------------

NET EARNINGS APPLICABLE TO
    COMMON SHAREHOLDERS                               470,754         217,333         807,461         485,313
                                                 ============    ============    ============    ============

NET EARNINGS PER SHARE:
    Basic                                        $       0.04    $       0.02    $       0.06    $       0.04
    Diluted                                      $       0.03    $       0.02    $       0.05    $       0.04


WEIGHTED AVERAGE COMMON SHARES:
    Basic                                          12,483,979      12,322,908      12,447,374      12,315,655
    Diluted                                        16,066,003      12,467,821      16,054,047      12,436,254
</TABLE>


See notes to consolidated financial statements.



                                       4
<PAGE>
                           HEALTH FITNESS CORPORATION
                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                                   (UNAUDITED)

<TABLE>
<CAPTION>
                                                                                    Six Months Ended
                                                                                        June 30,
                                                                                  2004            2003
<S>                                                                           <C>            <C>
CASH FLOWS  FROM OPERATING  ACTIVITIES:
   Net earnings                                                               $   850,661    $   485,313
   Adjustments to reconcile net earnings to net cash provided by
     (used in) operating activities:
       Depreciation of property and equipment                                      48,643         38,864
       Amortization of intangible assets                                          497,447             --
       Deferred taxes                                                             444,993        276,159
       Common stock issued for compensation                                        60,600             --
       Changes in operating assets and liabilities, net of assets acquired:
         Trade and other accounts receivable                                   (2,156,321)      (131,190)
         Prepaid expenses and other                                              (161,191)         5,728
         Other assets                                                              18,109       (217,233)
         Trade accounts payable                                                  (226,107)      (164,115)
         Accrued liabilities and other                                            654,281       (216,166)
         Deferred revenue                                                           6,476       (185,276)
                                                                              -----------    -----------
                Net cash provided by (used in) operating activities                37,591       (107,916)
                                                                              -----------    -----------

CASH FLOWS FROM INVESTING ACTIVITIES:
   Purchases of property and equipment                                            (49,612)      (100,718)
   Acquisition of business                                                       (193,566)            --
                                                                              -----------    -----------
                Net cash used in investing activities                            (243,178)      (100,718)
                                                                              -----------    -----------

CASH FLOWS FROM FINANCING ACTIVITIES:
   Borrowings under note payable                                                6,872,241      1,718,638
   Repayments of note payable                                                  (6,996,472)    (1,279,000)
   Proceeds from issuance of common stock                                          13,277         11,360
   Proceeds from the exercise of stock options                                     35,247             --
                                                                              -----------    -----------
                Net cash  provided by (used in) financing activities              (75,707)       450,998
                                                                              -----------    -----------

NET INCREASE (DECREASE) IN CASH                                                  (281,294)       242,364

CASH AT BEGINNING OF PERIOD                                                       281,294         91,658
                                                                              -----------    -----------

CASH AT END OF PERIOD                                                         $        --    $   334,022
                                                                              ===========    ===========

SUPPLEMENTAL CASH FLOW DISCLOSURES

Supplemental cash flow information

         Cash paid for interest                                               $   201,985    $    20,065

         Cash paid for taxes                                                       97,358         64,389

Noncash investing and financing activities affecting cash flows:

         Dividend to preferred shareholders                                        43,200             --
</TABLE>



See notes to consolidated financial statements.



                                       5
<PAGE>
                           HEALTH FITNESS CORPORATION
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                   (UNAUDITED)

NOTE 1. BASIS OF PRESENTATION

The accompanying unaudited consolidated financial statements have been prepared
in accordance with accounting principles generally accepted in the United States
of America for interim financial information. They should be read in conjunction
with the annual financial statements included in the Company's Annual Report on
Form 10-K for the year ended December 31, 2003. In the opinion of management,
the interim consolidated financial statements include all adjustments
(consisting of normal recurring accruals) necessary for the fair presentation of
the results for interim periods presented. Operating results for the three and
six months ended June 30, 2004 are not necessarily indicative of the operating
results for the year ending December 31, 2004.


NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Business - Health Fitness Corporation and its wholly owned subsidiaries (the
Company) provide fitness and wellness management services and programs to
corporations, hospitals, communities and universities located in the United
States and Canada. Fitness and wellness management services include the
development, marketing and management of corporate, hospital, community and
university based fitness centers, injury prevention and work-injury management
consulting, and on-site physical therapy. Programs include wellness and health
programs for individual customers, including health risk assessments, nutrition
and weight loss programs, smoking cessation, massage therapy, back care and
ergonomic injury prevention.

Consolidation - The consolidated financial statements include the accounts of
the Company and its wholly owned subsidiaries. All intercompany balances and
transactions have been eliminated in consolidation.

Cash - The Company maintains cash balances at several financial institutions,
and at times, such balances exceed insured limits. The Company has not
experienced any losses in such accounts and believes it is not exposed to any
significant credit risk on cash.

At June 30, 2004, the Company had cash overdrafts of $11,541 representing checks
written in excess of funds deposited, which are included in accounts payable for
financial statement presentation.

Trade and Other Accounts Receivable - Trade and other accounts receivable
represent amounts due from companies and individuals for services and products.
The Company grants credit to customers in the ordinary course of business, but
generally does not require collateral or any other security to support amounts
due. Management performs ongoing credit evaluations of customers. The Company
determines its allowance for discounts and doubtful accounts by considering a
number of factors, including the length of time trade accounts receivable are
past due, the Company's previous loss history, the customer's current ability to
pay its obligation to the Company, and the condition of the general economy and
the industry as a whole. The Company writes off accounts receivable when they
become uncollectible, and payments subsequently received on such receivable are
credited to the allowance. Concentrations of credit risk with respect to trade
receivables are limited due to the large number of customers and their
geographic dispersion.

Property and Equipment - Property and equipment is stated at cost. Depreciation
and amortization are computed using both straight-line and accelerated methods
over the useful lives of the assets.

Goodwill - Goodwill represents the excess of the purchase price and related
costs over the fair value of net assets of businesses acquired. The carrying
value of goodwill is not amortized, but is tested for impairment on an annual
basis or when factors indicating impairment are present. Projected discounted
cash flows are used in assessing these assets.


                                       6
<PAGE>
Intangible Assets - The Company's intangible assets include customer contracts,
trademark, and deferred financing costs and are amortized on a straight-line
basis. Customer contracts represent the fair value assigned to acquired
management contracts and are amortized over the remaining life of the contracts,
approximately 25-35 months. Trademark represents the value assigned to an
acquired trademark and is amortized over a period of five years. Deferred
financing costs are amortized over the term of the related credit agreement.

Cash Held In Escrow - Cash held in escrow represents the funds remaining after
payment of the purchase price for the Company's acquisition. Such funds will
remain in escrow until all parties subject to the escrow agreement agree that
all conditions related to the acquisition have been satisfied. At that time, any
funds remaining in escrow will be used to pay down the Company's long-term
obligations.

Revenue Recognition - Revenue is recognized at the time the service is provided
to the customer. For annual contracts, monthly amounts are recognized ratably
over the term of the contract. Certain services provided to the customer may
vary on a periodic basis and are invoiced to the customer in arrears. The
revenues relating to theses services are estimated in the month that the service
is performed.

Amounts received from customers in advance of providing the services of the
contract are treated as deferred revenue and recognized when the services are
provided.

The Company has contracts with third-parties to provide ancillary services in
connection with their fitness and wellness management services and programs.
Under such arrangements the third-parties invoice and receive payments from the
Company based on transactions with the ultimate customer. The Company does not
recognize revenues related to such transactions as the ultimate customer assumes
the risk and rewards of the contract and the amounts billed to the customer are
either at cost or with a fixed markup.

Comprehensive Income - Comprehensive income represents net earnings adjusted for
foreign currency translation adjustments. Total comprehensive income was
$804,042 and $485,313 for the six months ended June 30, 2004 and 2003.

Net Earnings Per Common Share - Basic net earnings per common share is computed
by dividing net earnings by the number of weighted average common shares
outstanding. Diluted net earnings per common share is computed by dividing net
earnings plus dividends to preferred shareholders by the number of weighted
average common shares outstanding, and common share equivalents relating to
stock options and stock warrants, when dilutive.

Fair Values of Financial Instruments - Due to their short-term nature, the
carrying value of the Company's current financial assets and liabilities
approximates their fair values. The fair value of long-term obligations, if
recalculated based on current interest rates, would not significantly differ
from the recorded amounts.

Use of Estimates - Preparing consolidated financial statements in conformity
with accounting principles generally accepted in the United States of America
requires management to make certain estimates and assumptions that affect the
reported amounts of assets and liabilities, disclosure of contingent assets and
liabilities at the date of the consolidated financial statements and the
reported amounts of revenues and expenses during the reporting period. Actual
results could differ from those estimates.


NOTE 3. PURCHASE OF ASSETS

On December 8, 2003 (the "Effective Date"), the Company purchased the business
assets of the Health & Fitness Services Business of Johnson & Johnson Health
Care Systems Inc. (JJHCS). Assets acquired by the Company consist primarily of
client contracts, proprietary wellness, lifestyle and health promotion programs,


                                       7
<PAGE>
software, and other health and wellness services. As part of the transaction,
the Company entered into a multi-year management contract with another
subsidiary of Johnson & Johnson whereby the Company will manage more than 50
Johnson & Johnson affiliate fitness center sites. The Company also entered into
a one-year agreement to use 660 square feet of office space of JJHCS for a fee
of $1,500 per month.

The acquisition has been accounted for using the purchase method of accounting.
The fair market value of the assets acquired resulted in the following purchase
price allocation:

<TABLE>
<S>                                                                <C>
           Cash price paid for assets                              $4,927,500
           Acquisition costs incurred                                 836,879
                                                                   ----------
                 Total purchase price                              $5,764,379
                                                                   ==========

           Purchase Price Allocation
           Inventory                                               $   40,000
           Property and equipment                                      34,000
           Customer contracts                                       1,730,000
           Trademark                                                  350,000
           Excess of cost over assets acquired                      3,610,379
                                                                   ----------
                                                                   $5,764,379
                                                                   ==========
</TABLE>


During the six months ended June 30, 2004, an additional $142,111 was paid to
JJHCS for two contract assignments. The Company also incurred an additional
$51,455 of acquisition related costs. This additional purchase price was
recorded to goodwill.


NOTE 4. FINANCING

On August 22, 2003, the Company entered into a $7,500,000 Credit Agreement with
Wells Fargo Bank, N.A. to provide the Company with acquisition financing and
general working capital (the Wells Loan). The initial draw on the Wells Loan
totaled $1,255,204, which was used to refinance a revolving line of credit with
Merrill Lynch Business Financial Services, Inc. (the Merrill Lynch Loan). The
Company repaid all amounts owed to Merrill Lynch Business Financial Services,
Inc. and canceled the line of credit, which accrued interest at the one-month
LIBOR rate plus 2.35%. On August 25, 2003, the Company made a draw of $2,250,000
on the Wells Loan, the proceeds of which were placed into escrow to fund a
portion of the JJHCS asset purchase.

Working capital advances from the Wells Loan are based upon a percentage of the
Company's eligible accounts receivable, less any amounts previously drawn. At
the option of the Company, the Wells Loan bears interest at prime or the
one-month LIBOR plus a margin of 2.25% to 2.75% based upon the Company's Senior
Leverage Ratio (effective rate of 4.25% at June 30, 2004 and 4.00% at December
31, 2003). The availability of the Wells Loan will decrease $250,000 on the last
day of each calendar quarter, beginning September 30, 2003, and will expire on
June 30, 2007. Borrowing capacity under the Wells Loan totaled $6,500,000 and
$7,000,000 at June 30, 2004 and December 31, 2003. At June 30, 2004, the Company
had $2,650,770 outstanding under the Wells Loan. Borrowings under the Wells Loan
are collateralized by substantially all of the Company's assets. The Company is
required to comply with certain monthly financial covenants, including a fixed
charge coverage ratio, minimum earnings before interest, taxes, depreciation and
amortization, cash flow leverage ratio and a balance sheet leverage ratio.
Beginning on January 31, 2004 and continuing to May 14, 2004, the Company was
not in compliance with certain covenants relating to the Wells Loan. On May 14,
2004, Wells Fargo agreed to waive the noncompliance and amend the loan
covenants, effective as of January 31, 2004. The Company believes the new loan
covenants are more appropriate after taking into consideration the Company's
actual financial position following the acquisition of the business assets of
JJHCS. Wells Fargo was made aware of the noncompliance shortly after January 31,
2004 and agreed to continue making capital advances


                                       8
<PAGE>
available to the Company throughout the period as new loan covenants were
negotiated. Therefore, the noncompliance had no impact on the Company's
liquidity, capital resources or results of operations. At June 30, 2004, the
Company was in compliance with all of the new loan covenants.

On August 25, 2003, the Company entered into a $3,000,000 Securities Purchase
Agreement with Bayview Capital Partners LP ("Bayview") to provide the Company
with acquisition financing and general working capital (the "Bayview
Investment"). The Bayview Investment was initially structured as a bridge note
(the "Bridge Note"), the proceeds of which were placed into escrow to fund a
portion of the JJHCS asset purchase.

On December 8, 2003 (the "Effective Date"), the $3,000,000 Bridge Note issued to
Bayview was converted into a $2,000,000 term note (the "Term Note"), $1,000,000
of Series A Convertible Preferred Stock, $0.01 par value (the "Preferred Stock")
and a warrant to purchase common stock of the Company (the "Warrant") per the
terms set forth in the August 25, 2003 Securities Purchase Agreement. The Term
Note bears interest at 12% per year, payable monthly, and will mature on the
fifth anniversary of the Effective Date. The Term Note may be prepaid, in whole
or in part, at any time, provided that the prepayment is accompanied by a
premium ranging from 5% in year 1 to 1% in year 5. The Bayview Investment is
secured by a subordinated security interest in substantially all of the
Company's assets. The Bayview Investment contained identical financial covenants
to those in the Wells Loan described above, and on May 14, 2004 Bayview agreed
to join with Wells Fargo in waiving this noncompliance and amending the
covenants. The noncompliance with these financial covenants had no impact on the
Company's liquidity, capital resources or results of operations, and the Company
believes the amended covenants are more appropriate after taking into
consideration the Company's actual financial position following the acquisition
of the business assets of JJHCS. At June 30, 2004, the Company was in compliance
with all of its new loan covenants.

The Preferred Stock was issued to Bayview at a price of $1.00 per share,
resulting in 1,000,000 shares issued on the Effective Date. The Preferred Stock
has a stated dividend rate of 6% per year, computed on a simple interest basis,
paid in kind in the form of additional shares of Preferred Stock using a price
of $1.00 per share ("PIK Dividends"). At the option of the holder, the Preferred
Stock, including any PIK Dividends, may be converted, at any time and from time
to time, into common stock of the Company at a price of $0.50 per share. In
addition, Bayview may require redemption of the Preferred Stock and PIK
Dividends upon a change of control or default (including default under the Term
Note).

         The Warrant issued to Bayview on the Effective Date represents the
right to purchase 1,210,320 shares of common stock, which represented 8% of the
Company's common stock outstanding on a fully diluted basis at the Effective
Date, excluding the common stock issuable to Bayview upon conversion of the
Preferred Stock. The Warrant is exercisable at any time for a period of ten
years at an exercise price equal to $0.50 per share, and the shares obtainable
upon exercise of the Warrant may be put to the Company at fair market value (net
of the exercise price) upon a change of control or default.

The investment proceeds received from Bayview were allocated based upon the
relative fair value of each instrument, which resulted in the following
allocation:

<TABLE>
<S>                                                                 <C>
       Value assigned to Preferred Stock                            $  783,904
       Value assigned to Warrants                                      648,288
       Value assigned to Term Note                                   1,567,808
                                                                    ----------
                                                                    $3,000,000
                                                                    ==========
</TABLE>


The $432,192 difference between the $2,000,000 face value of the Term Note and
its assigned relative fair value is being amortized as interest expense over the
5-year term of the Term Note. Balances of long-term obligations are as follows:


                                       9
<PAGE>
<TABLE>
<CAPTION>
                                                       June 30,     December 31,
                                                         2004          2003
                                                     -----------    ------------
<S>                                                  <C>            <C>
           Wells Loan                                $ 2,650,770    $ 2,775,000
           Bayview Term Note                           2,000,000      2,000,000
                                                     -----------    -----------
                                                       4,650,770      4,775,000
           Discount on Bayview Term Note                (381,770)      (424,988)
                                                     -----------    -----------
                                                     $ 4,269,000    $ 4,350,012
                                                     ===========    ===========
</TABLE>


Outstanding principal balances on the Wells Loan and Bayview Term Note mature in
June 2007 and August 2008, respectively.


NOTE 5. STOCK-BASED COMPENSATION

The Company utilizes the intrinsic value method of accounting for its stock
based employee compensation plans. All options granted had an exercise price
equal to the market value of the underlying common stock on the date of grant
and accordingly, no compensation cost is reflected in net earnings for the three
and six months ended June 30, 2004 and 2003. The following table illustrates the
effect on net earnings and earnings per share if the Company had applied the
fair value method of accounting for stock options:

<TABLE>
<CAPTION>
                                                Three Months ended          Six Months ended
                                                     June 30,                   June 30,
                                              ----------------------    ------------------------
                                                 2004         2003         2004          2003
                                              ---------    ---------    ---------    -----------
<S>                                           <C>          <C>          <C>          <C>
Net earnings, applicable to common
  Shareholders - basic                        $ 470,754    $ 217,333    $ 807,461    $   485,313
Add:  Dividends to preferred shareholders        28,200           --       43,200             --
                                              ---------    ---------    ---------    -----------
Net earnings - diluted                          498,954      217,333      850,661        485,313
                                              ---------    ---------    ---------    -----------
Less: Compensation expense determined under
the fair value method, net of tax               (90,371)     (25,316)    (113,992)       (37,306)
                                              ---------    ---------    ---------    -----------
Proforma net earnings - basic                 $ 380,383    $ 192,017    $ 693,469    $   448,007
                                              =========    =========    =========    ===========
Proforma net earnings - diluted               $ 408,583    $ 192,017    $ 736,669    $   448,007
                                              =========    =========    =========    ===========

Earnings per Share:
   Basic, as reported                         $    0.04    $    0.02    $    0.06    $      0.04
                                              =========    =========    =========    ===========
   Basic, proforma                            $    0.03    $    0.02    $    0.06    $      0.04
                                              =========    =========    =========    ===========

   Diluted, as reported                       $    0.03    $    0.02    $    0.05    $      0.04
                                              =========    =========    =========    ===========
   Diluted, proforma                          $    0.03    $    0.02    $    0.05    $      0.04
                                              =========    =========    =========    ===========
</TABLE>


The proforma information above should be read in conjunction with the related
historical information.

The fair value of each option grant is estimated on the grant date using the
Black-Scholes option-pricing model with the following assumptions and results
for the grants:

<TABLE>
<CAPTION>
                                                                            2004               2003
                                                                         ---------          ---------
<S>                                                                      <C>                <C>
         Dividend yield                                                    None               None
         Expected volatility                                                88%                90%
         Expected life of option                                         1-4 years          1-4 years
         Risk-free interest rate                                           3.27%              2.9%
         Weighted average fair value of options on grant date              $1.01             $0.24
</TABLE>



                                       10
<PAGE>
NOTE 6. INCOME TAXES

The Company records income taxes in accordance with the liability method of
accounting. Deferred income taxes are provided for temporary differences between
the financial reporting and tax basis of assets and liabilities and federal
operating loss carryforwards. Deferred tax assets and liabilities are adjusted
for the effects of changes in tax laws and rates on the date of the enactment.
Income taxes are calculated based on management's estimate of the Company's
effective tax rate, which takes into consideration a federal tax rate of 34% and
a state tax rate of 6%.


NOTE 7. STOCK OPTIONS

The Company maintains a stock option plan for the benefit of certain eligible
employees and directors of the Company. A total of 1,530,350 shares of common
stock are reserved for additional grants of options under the plan at June 30,
2004. Generally, the options outstanding (1) are granted at prices equal to the
market value of the stock on the date of grant, (2) vest over various terms and,
(3) expire over a period of five or ten years from the date of grant.

A summary of stock option activity for the six months ended June 30, 2004 is as
follows:

<TABLE>
<CAPTION>
                                                                            Weighted
                                                     Number of               Average
                                                       Shares             Exercise Price
                                                     ----------           --------------
<S>                                                  <C>                  <C>
         Outstanding at December 31, 2003             1,710,900               $0.88
           Granted                                      165,100                2.07
           Exercised                                    (59,750)               0.53
           Forfeited                                    (31,250)               0.44
                                                     ----------
         Outstanding at March 31, 2004                1,785,000                1.01
           Granted                                      120,000                1.51
           Exercised                                     (6,350)               0.53
           Forfeited                                     (1,350)               0.47
                                                     ----------
         Outstanding at June 30, 2004                 1,897,300               $1.04
                                                     ==========
</TABLE>



                                       11

<PAGE>


ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
        OF OPERATIONS

The following discussion and analysis of our financial condition and results of
operations should be read in conjunction with our consolidated financial
statements and related notes included in Item 1 of Part 1 of this Quarterly
Report and the audited consolidated financial statements and notes thereto and
Management's Discussion and Analysis of Financial Condition and Results of
Operations contained in the Company's Annual Report on Form 10-K for the fiscal
year ended December 31, 2003.

CRITICAL ACCOUNTING POLICIES. Our most critical accounting policies, which are
those that require significant judgment, include: revenue recognition, trade and
other accounts receivable, goodwill and stock-based compensation. A more
in-depth description of these can be found in our Annual Report on Form 10-K for
the fiscal year ended December 31, 2003.

GENERAL. Health Fitness Corporation and its wholly owned subsidiaries (the
Company), provide fitness and wellness management services and programs to
corporations, hospitals, communities and universities located in the United
States of America and Canada. Fitness and wellness management services include
the development, marketing and management of corporate, hospital, community and
university-based fitness centers, injury prevention and work-injury management
consulting, and on-site physical therapy and occupational health services.
Programs include wellness and health programs for individual customers,
including health risk assessments, nutrition and weight loss programs, smoking
cessation, massage therapy, back care and ergonomic injury prevention.

RESULTS OF OPERATIONS FOR THE QUARTER ENDED JUNE 30, 2004 AS COMPARED TO THE
QUARTER ENDED JUNE 30, 2003.

REVENUE. Revenues increased $5,397,000, or 69.8%, to $13,130,000 for the three
months ended June 30, 2004, from $7,733,000 for the three months ended June 30,
2003. This increase is primarily attributed to the acquisition of the business
assets of the Health & Fitness Services Business of Johnson & Johnson Health
Care Systems Inc. ("JJHCS").

GROSS PROFIT. Gross profit increased $1,861,000, or 117.7%, to $3,442,000 for
the three months ended June 30, 2004, from $1,581,000 for the three months ended
June 30, 2003. This increase is primarily attributed to the acquisition of
JJHCS. In addition, the JJHCS acquisition improved gross profit as a percent of
revenue, increasing to 26.2% for the three months ended June 30, 2004, compared
to 20.4% for the three months ended June 30, 2003.

OPERATING EXPENSES AND OPERATING INCOME. Operating expenses increased $1,262,000
to $2,473,000 for the three months ended June 30, 2004 from $1,211,000 for the
three months ended June 30, 2003. Of this increase, $220,000 represents a
non-cash expense related to the amortization of acquired intangible assets. The
remaining increase of $1,042,000 is primarily attributed to the cost of
salaries, benefits and other expenses of the management team of JJHCS.

OTHER INCOME AND EXPENSE. Interest expense increased $115,000 to $128,000 for
the three months ended June 30, 2004, compared to $13,000 for the same period in
2003. This increase is due to debt facilities the company secured to finance the
JJHCS acquisition and to provide working capital for the combined company. The
Company's cost of borrowed funds increased to an average of 6.7% for the second
quarter of 2004 from 3.5% for the second quarter of 2003.


                                       12
<PAGE>
INCOME TAXES. Income tax expense increased $204,000 to $343,000 for the three
months ended June 30, 2004 compared to $139,000 for the same period in 2003. The
increase is primarily due to the increase in operating profit.

DIVIDENDS TO PREFERRED SHAREHOLDERS. To finance the Company's acquisition of
JJHCS, the Company sold $1,000,000 of Preferred Stock to Bayview. The Preferred
Stock was issued at a price of $1.00 per share, resulting in the issuance of
1,000,000 shares. The Preferred Stock has a stated dividend rate of 6% per year,
computed on a simple interest basis, paid in kind in the form of additional
shares of Preferred Stock using a price of $1.00 per share ("PIK Dividends").
For the quarter ended June 30, 2004, the Company accrued dividends of $28,000,
including a dividend of approximately $13,000 related to a beneficial conversion
feature associated with the PIK Dividends.

NET EARNINGS APPLICABLE TO COMMON SHAREHOLDERS. As a result of the above, net
earnings applicable to common shareholders for the three months ended June 30,
2004 increased $254,000, or 117.0%, to $471,000 from $217,000 for the three
months ended June 30, 2003.

RESULTS OF OPERATIONS FOR THE SIX MONTHS ENDED JUNE 30, 2003 AS COMPARED TO THE
SIX MONTHS ENDED JUNE 30, 2002.

REVENUE. Revenues increased $10,545,000, or 69.1%, to $25,796,000 for the six
months ended June 30, 2004, from $15,251,000 for the six months ended June 30,
2003. This increase is primarily attributed to the acquisition of JJHCS.

GROSS PROFIT. Gross profit increased $3,293,000, or 101.8%, to $6,529,000 for
the six months ended June 30, 2004, from $3,236,000 for the six months ended
June 30, 2003. This increase is primarily attributed to the acquisition of
JJHCS. In addition, the JJHCS acquisition improved gross profit as a percent of
revenue, increasing to 25.3% for the six months ended June 30, 2004 compared to
21.2% for the six months ended June 30, 2003.

OPERATING EXPENSES AND OPERATING INCOME. Operating expenses increased $2,461,000
to $4,865,000 for the six months ended June 30, 2004 from $2,404,000 for the six
months ended June 30, 2003. Of this increase, $439,000 represents a non-cash
expense related to the amortization of acquired intangible assets. The remaining
increase of $2,022,000 is primarily attributed to the cost of salaries, benefits
and other expenses of the management team of JJHCS.

OTHER INCOME AND EXPENSE. Interest expense increased $239,000 to $263,000 for
the six months ended June 30, 2004, compared to $24,000 for the same period in
2003. This increase is due to debt facilities the company secured to finance the
JJHCS acquisition and to provide working capital for the combined company. The
Company's cost of borrowed funds increased to an average of 6.8% for the six
months ended June 30, 2004 from 3.7% for the same period in 2003.

INCOME TAXES. Income tax expense increased $231,000 to $552,000 for the six
months ended June 30, 2004 compared to $321,000 for the same period in 2003. The
increase is primarily due to the increase in operating profit.

DIVIDENDS TO PREFERRED SHAREHOLDERS. For the six months ended June 30, 2004, the
Company accrued dividends on the Preferred Stock held by Bayview in the amount
of $43,000, including a dividend of approximately $13,000 related to a
beneficial conversion feature associated with the PIK Dividends.


                                       13
<PAGE>
NET EARNINGS APPLICABLE TO COMMON SHAREHOLDERS. As a result of the above, net
earnings applicable to common shareholders for the six months ended June 30,
2004 increased $322,000, or 66.4%, to $807,000 from $485,000 for the six months
ended June 30, 2003.

LIQUIDITY AND CAPITAL RESOURCES

The Company's working capital increased $1,848,000 to $4,103,000 at June 30,
2004, compared to working capital of $2,255,000 at December 31, 2003. The
increase in working capital is primarily due to an increase in accounts
receivable resulting from the fitness and wellness management contracts acquired
in the JJHCS transaction.

On August 22, 2003, the Company entered into a $7,500,000 Credit Agreement with
Wells Fargo Bank, N.A. to provide the Company with acquisition financing and
general working capital (the Wells Loan). The initial draw on the Wells Loan
totaled $1,255,204, which was used to refinance a revolving line of credit with
Merrill Lynch Business Financial Services, Inc. (the Merrill Lynch Loan). The
Company repaid all amounts owed to Merrill Lynch Business Financial Services,
Inc. and canceled the line of credit, which accrued interest at the one-month
LIBOR rate plus 2.35%. On August 25, 2003, the Company made a draw of $2,250,000
on the Wells Loan, the proceeds of which were placed into escrow to fund a
portion of the JJHCS asset purchase.

Working capital advances from the Wells Loan are based upon a percentage of the
Company's eligible accounts receivable, less any amounts previously drawn. At
the option of the Company, the Wells Loan bears interest at prime or the
one-month LIBOR plus a margin of 2.25% to 2.75% based upon the Company's Senior
Leverage Ratio (effective rate of 4.25% at June 30, 2004 and 4.00% at December
31, 2003). The availability of the Wells Loan will decrease $250,000 on the last
day of each calendar quarter, beginning September 30, 2003, and will expire on
June 30, 2007. Borrowing capacity under the Wells Loan totaled $6,500,000 and
$7,000,000 at June 30, 2004 and December 31, 2003. At June 30, 2004 the Company
had $2,650,770 outstanding under the Wells Loan. Borrowings under the Wells Loan
are collateralized by substantially all of the Company's assets. The Company is
required to comply with certain monthly financial covenants, including a fixed
charge coverage ratio, minimum earnings before interest, taxes, depreciation and
amortization, cash flow leverage ratio and a balance sheet leverage ratio.
Beginning on January 31, 2004 and continuing to May 14, 2004, the Company was
not in compliance with certain covenants relating to the Wells Loan. On May 14,
2004, Wells Fargo agreed to waive the noncompliance and amend the loan
covenants, effective as of January 31, 2004. The Company believes the new loan
covenants are more appropriate after taking into consideration the Company's
actual financial position following the acquisition of the business assets of
JJHCS. Wells Fargo was made aware of the noncompliance shortly after January 31,
2004 and agreed to continue making capital advances available to the Company
throughout the period as new loan covenants were negotiated. Therefore, the
noncompliance had no impact on the Company's liquidity, capital resources or
results of operations. At June 30, 2004, the Company was in compliance with all
of the new loan covenants.

On August 25, 2003, the Company entered into a $3,000,000 Securities Purchase
Agreement with Bayview to provide the Company with acquisition financing and
general working capital (the "Bayview Investment"). The Bayview Investment was
initially structured as a bridge note (the "Bridge Note"), the proceeds of which
were placed into escrow to fund a portion of the JJHCS asset purchase.

On December 8, 2003 (the "Effective Date"), the $3,000,000 Bridge Note issued to
Bayview was converted into a $2,000,000 term note (the "Term Note"), $1,000,000
of Preferred Stock and a warrant to purchase common stock of the Company (the
"Warrant") per the terms set forth in the August 25, 2003 Securities Purchase
Agreement. The Term Note bears interest at 12% per year, payable monthly, and
will mature on the fifth anniversary of the Effective Date. The Term Note may be
prepaid, in whole or in part, at any time, provided that the prepayment is
accompanied by a premium ranging from 5% in year 1 to 1% in year 5. The Bayview
Investment is secured by a subordinated security interest in substantially all
of the Company's assets. The


                                       14
<PAGE>
Bayview Investment is secured by a subordinated security interest in
substantially all of the Company's assets. The Bayview Investment contained
identical financial covenants to those in the Wells Loan described above, and on
May 14, 2004 Bayview agreed to join with Wells Fargo in waiving this
noncompliance and amending the covenants. The noncompliance with these financial
covenants had no impact on the Company's liquidity, capital resources or results
of operations, and the Company believes the amended covenants are more
appropriate after taking into consideration the Company's actual financial
position following the acquisition of the business assets of JJHCS. At June 30,
2004, the Company was in compliance with all of its new loan covenants.

The Preferred Stock was issued to Bayview at a price of $1.00 per share,
resulting in 1,000,000 shares issued on the Effective Date. The Preferred Stock
has a stated dividend rate of 6% per year, computed on a simple interest basis,
paid in kind in the form of additional shares of Preferred Stock using a price
of $1.00 per share ("PIK Dividends"). At the option of the holder, the Preferred
Stock, including any PIK Dividends, may be converted, at any time and from time
to time, into common stock of the Company at a price of $0.50 per share. In
addition, Bayview may require redemption of the Preferred Stock and PIK
Dividends upon a change of control or default (including default under the Term
Note).

As of June 30, 2004, the Company did not maintain a cash balance as available
funds were used to pay down the Wells Loan. In addition, the Company has no
off-balance sheet arrangements or transactions with unconsolidated, limited
purpose entities. Refer to the footnotes in the Company's Annual Report on Form
10-K for the year ended December 31, 2003 for disclosure related to the
Company's "Commitments and Contingencies."

On a short and long-term basis, the Company believes that sources of capital to
meet future obligations will be provided by cash generated through operations
and the Company's revolving line of credit. The Company does not believe that
inflation has had a significant impact on the results of its operations.

RECENTLY ISSUED ACCOUNTING POLICIES

As indicated in our notes to the financial statements, we are not aware of any
recently issued accounting pronouncements that will have a material impact on
the Company's financial position or results of operations.

RECENTLY PASSED LEGISLATION

HIPPA. The Administrative Simplification provisions of the Health Insurance
Portability and Accountability Act of 1996, or HIPAA, require group health plans
and health care providers who conduct certain administrative and financial
transactions electronically to (a) comply with a certain data format and coding
standards when conducting electronic transactions; (b) use appropriate
technologies to protect the security and integrity of individually identifiable
health information transmitted or maintained in an electronic format; and (c)
protect the privacy of patient health information. The Company's occupational
health line of business, which accounts for approximately five percent of the
Company's total revenue, and the group health plan the Company sponsors for its
employees are subject to HIPAA's requirements. The Company expects to be in
compliance with HIPPA requirements within the timeline specified for the
Company's affected business areas. The Company's corporate, hospital, community
and university based fitness center management lines of business are not subject
to the requirements of HIPAA.

CAUTIONARY STATEMENT

 The foregoing discussion and other statements in this report contain various
"forward-looking statements" within the meaning of Section 27A of the Securities
Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934,
as amended. Forward-looking statements are based on current expectations or
beliefs concerning future events. Such statements can be identified by the use
of terminology such as "anticipate,"


                                       15
<PAGE>
 "believe," "estimate," "expect," "intend," "may," "could," "possible," "plan,"
"project," "will," "forecast" and similar words or expressions, specifically
including a statement regarding the Company's belief that sources of capital to
meet future obligations will be provided by cash generated through operations
and its revolving line of credit. These forward-looking statements are not
guarantees of future performance and involve a number of risks and uncertainties
that may cause the Company's actual results to differ materially from the
results discussed in these statements. Please refer to Management's Discussion
and Analysis contained within the Company's Annual Report on Form 10-K for the
year ended December 31, 2003, for cautionary statements on important factors to
consider in evaluating the forward-looking statements included in this Form
10-Q.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The Company has no history of, and does not anticipate in the future, investing
in derivative financial instruments, derivative commodity instruments or other
such financial instruments. Transactions with international customers are
entered into in U.S. dollars, precluding the need for foreign currency hedges.
As a result, the exposure to market risk is not material.

ITEM 4. CONTROLS AND PROCEDURES

The Company's Chief Executive Officer and Chief Financial Officer (collectively,
the "Certifying Officers") are responsible for establishing and maintaining
disclosure controls and procedures for the Company. The Certifying Officers have
concluded (based upon their evaluation of these controls and procedures as of
the end of the period covered by this report) that the Company's disclosure
controls and procedures are effective to ensure that information required to be
disclosed by the Company in reports that it files or submits under the Exchange
Act is recorded, processed, summarized and reported within the time periods
specified in the rules of the Securities and Exchange Commission. The Certifying
Officers also have indicated that there were no significant changes in the
Company's internal control over financial reporting that occurred during the
period covered by this report that have materially affected, or are reasonably
likely to materially affect, the Company's internal control over financial
reporting.


                                       16
<PAGE>
PART II. - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

Refer to Item 3 (Legal Proceedings) of the Company's Annual Report on Form 10-K
for the year ended December 31, 2003.

ITEM 2. CHANGES IN SECURITIES, USE OF PROCEEDS AND ISSUER PURCHASES OF EQUITY
SECURITIES

At the Annual Meeting of Shareholders on May 18, 2004, the Company's
shareholders approved an increase in the number of shares of capital stock that
the Company is authorized to issue from 30,000,000 to 60,000,000, of which
50,000,000 shall be designated as common shares and 10,000,000 shall be
designated as preferred stock.

ITEM 3.  DEFAULTS UPON SENIOR SECURITIES

Beginning on January 31, 2004 and continuing to May 14, 2004, the Company was
not in compliance with certain covenants relating to the Wells Loan. The Company
also was not in compliance with the identical covenants set forth in the
Securities Purchase Agreement with Bayview pertaining to a $2,000,000 term note
and $1,000,000 of Preferred Stock issued to Bayview on December 8, 2003. Wells
Fargo continued to make working capital available throughout this period of
noncompliance, and on May 14, 2004, Wells Fargo and Bayview agreed to waive the
noncompliance and to amend the covenants, effective as of January 31, 2004.
Therefore, the noncompliance had no impact on the Company's liquidity, capital
resources or results of operations. At June 30, 2004 the Company was in
compliance with all new loan covenants.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

      (a) The Annual Meeting of the Company's shareholders was held on Tuesday,
      May 18, 2004.

      (b) Proxies for the Annual Meeting were solicited pursuant to Regulation A
      under the Securities Exchange Act of 1934, there was no solicitation in
      opposition to management's nominees, and the following persons were
      elected directors of the Company to serve until the next annual meeting of
      shareholders:
<TABLE>
<CAPTION>
      Nominee                  Number of Votes For    Number of Votes Withheld
      -------                  -------------------    ------------------------
<S>                            <C>                    <C>
      James A. Bernards                 10,798,552                     226,656
      K. James Ehlen, M.D               10,416,473                     608,735
      Jerry V. Noyce                    10,976,998                      48,210
      John C. Penn                      10,760,448                     264,760
      Mark W. Sheffert                  10,978,548                      46,660
      Linda Hall Whitman                10,717,778                     307,430
      Rodney A. Young                   10,717,878                     307,330
      Cary Musech                       10,798,552                     226,656
</TABLE>

      (c) By a vote of 4,852,628 shares in favor, 626,316 shares opposed, 41,895
      shares abstaining, and 5,504,369 shares represented by broker nonvotes,
      the shareholders approved an increase in the number of shares of capital
      stock that the Company is authorized to issue, from 30,000,000 to
      60,000,000 shares, of which 50,000,000 shall be designated as common
      shares and 10,000,000 shall be designated as preferred stock.



                                       17
<PAGE>
      (d) By a vote of 4,838,896 shares in favor, 635,856 shares opposed, 46,087
      shares abstaining, and 5,504,369 shares represented by broker nonvotes,
      the shareholders approved a 1,500,000 share increase in the number of
      shares reserved for the Company's 1995 Stock Option Plan.

      (e) By a vote of 10,961,163 shares in favor, 9,300 shares opposed, 54,745
      shares abstaining, and no shares represented by broker nonvotes, the
      shareholders approved the selection of Grant Thornton LLP as the Company's
      independent auditors for the current fiscal year.

      ITEM 5. OTHER INFORMATION

      None.

      ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

      (a) Exhibits

      See Exhibit Index on page following signatures

      (b) Reports on Form 8-K

      On May 10, 2004, the Company filed a Form 8-K providing a press release
      dated May 4, 2004 regarding its 2004 first quarter financial results.

      On May 20, 2004, the Company filed a Form 8-K providing certain
      forward-looking statements and other information regarding management's
      2004 financial goals and business priorities that the Company presented at
      its annual shareholder meeting on May 18, 2004.

      On June 10, 2004, the Company filed a Form 8-K providing a press release
      dated June 10, 2004 announcing that Robert J. Marzec, former audit partner
      of the Minneapolis office of PricewaterhouseCoopers, has been named to its
      board of directors


                                       18
<PAGE>
                                   SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange
Act of 1934, the Company has duly caused this Report to be signed on its behalf
by the undersigned, thereunto duly authorized.

Dated:  August 12, 2004
HEALTH FITNESS CORPORATION.


By       /s/ Jerry V. Noyce
  ----------------------------------
Jerry V. Noyce
Chief Executive Officer
(Principal Executive Officer)


By       /s/ Wesley W. Winnekins
   ---------------------------------
Wesley W. Winnekins
Chief Financial Officer
(Principal Financial and Accounting Officer)



                                       19
<PAGE>
                                  EXHIBIT INDEX
                           HEALTH FITNESS CORPORATION
                                   FORM 10-Q

    Exhibit #       Description

      *11.0         Statement re: Computation of Earnings per Share

      *31.1         Certification of Chief Executive Officer Pursuant to
                    Section 302 of the Sarbanes-Oxley Act of 2002

      *31.2         Certification of Chief Financial Officer Pursuant to
                    Section 302 of the Sarbanes-Oxley Act of 2002

      *32.1         Certification of Chief Executive Officer Pursuant to
                    Section 906 of the Sarbanes-Oxley Act of 2002

      *32.2         Certification of Chief Financial Officer Pursuant to
                    Section 906 of the Sarbanes-Oxley Act of 2002

---------------------
*  Filed herewith


                                       20